# Risk factors for depression in systemic lupus erythematosus: a systematic review and meta-analysis

**Authors:** Linling Zhu, Jinju Chen, Yaping Sha, Huiren Zhuang, Chunhua Ye

PMC · DOI: 10.3389/fmed.2026.1751870 · Frontiers in Medicine · 2026-02-19

## TL;DR

This study identifies risk factors for depression in people with lupus, including financial stress and high medication use, to help improve early detection and care.

## Contribution

The study provides a comprehensive meta-analysis of depression risk factors in systemic lupus erythematosus patients using validated scales.

## Key findings

- Economic hardship and high-dose glucocorticoid use strongly increase depression risk in SLE patients.
- Younger age and greater fatigue severity are also significant risk factors for depression in this population.
- Geographic region and depression assessment tools contribute to variability in study results.

## Abstract

Depression is highly prevalent among patients with systemic lupus erythematosus (SLE) and is associated with adverse clinical outcomes. However, evidence on its risk factors remains inconsistent, limiting early identification and targeted intervention.

We conducted a systematic review and meta-analysis in accordance with PRISMA and MOOSE guidelines. Eight databases were searched from inception to May 2024 for observational studies reporting risk factors for depression in adult SLE patients assessed by validated scales. Study quality was evaluated using the Newcastle–Ottawa Scale or AHRQ criteria. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using random-effects models.

A total of 26 studies (n = 8,960 patients) were included. Significant risk factors for depression included economic hardship (OR = 6.05, 95% CI: 3.64–10.07), high-dose glucocorticoid use (OR = 7.72, 95% CI: 4.62–12.90), higher disease activity (OR = 3.15, 95% CI: 2.95–3.37), unemployment (OR = 3.06, 95% CI: 1.48–6.32), lower academic qualifications (OR = 2.21, 95% CI: 1.45–3.36), presence of comorbidities (OR = 2.20, 95% CI: 1.45–3.34), smoking (OR = 3.17, 95% CI: 1.44–6.99), and greater fatigue severity (per unit increase: OR = 1.23, 95% CI: 1.08–1.40). Younger age was also associated with higher depression risk (OR = 1.97, 95% CI: 1.41–2.76). Subgroup and meta-regression analyses revealed substantial heterogeneity across studies, partially explained by geographic region and depression assessment tools. Publication bias was detected but did not alter core findings in sensitivity analyses.

This meta-analysis identifies key clinical, demographic, and psychosocial risk factors for depression in SLE. Findings support integrating routine depression screening with holistic assessments of disease burden and social context in clinical practice, particularly within nursing-led care models.

https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024557892, identifier CRD42024557892.

## Linked entities

- **Diseases:** systemic lupus erythematosus (MONDO:0007915), depression (MONDO:0002050)

## Full-text entities

- **Genes:** C3 (complement C3) [NCBI Gene 718] {aka AHUS5, ARMD9, ASP, C3a, C3b, CPAMD1}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** pain (MESH:D010146), inflammation (MESH:D007249), Comorbidity (MESH:D004194), sleep disruption (MESH:D019958), Anxiety (MESH:D001007), neuroinflammation (MESH:D000090862), insomnia (MESH:D007319), psychiatric (MESH:D001523), to body image (MESH:D057215), Fatigue (MESH:D005221), mood disorders (MESH:D019964), somatic symptoms (MESH:D000071896), Smoking (MESH:D015208), autoimmune disease (MESH:D001327), Disseminated Lupus Erythematosus (MESH:D008180), mood lability (MESH:D005166), distress (MESH:D012128), rheumatic diseases (MESH:D012216), psychosis (MESH:D011618), neuropsychiatric (MESH:C000631768), Depression (MESH:D003866), immune dysregulation (OMIM:614878)
- **Chemicals:** monoamine (-), steroid (MESH:D013256)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960599/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12960599/full.md

## References

64 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960599/full.md

---
Source: https://tomesphere.com/paper/PMC12960599